Our Funding
EUPATI is co-financed by in-cash contribution from industry partners and in-kind contribution from public partners, as well as fee-based services to ensure continuous education and reliable information for patients, patient representatives and the wider public. In addition, EUPATI receives funding in the form of projects/grants supported by e.g. European funding schemes IMI/IHI, EIT Health and EU4Health. EUPATI is also supported by organisational and individual donations.
The sustainability plan for EUPATI is based on a mixed business model with different interconnected funding streams serving to sustain the core EUPATI activities (The EUPATI Patient Expert Training Programme, the EUPATI toolbox and the EUPATI National Platforms) and enabling a widening of EUPATI’s scope. The objective is to have a balanced public-private funding base.
EUPATI is registered in the EU Transparency Register with registration number 172647094262-11.
Our Main Sources of Funding
Learning Lab
Seeking to expand the scope of EUPATI to training for all stakeholders – including pharmaceutical industry, other health-related industry, academia, regulators and HTA bodies – EUPATI provides fee-for-service training/courses about patient involvement. The target groups are professionals working in a) patient relations/involvement management and b) in operational roles looking to involve patients.
Partner Contributions
The ‘Co-financing’ of EUPATI provided by the private and public partners can take the form of both, ‘in-kind’ contributions, or direct financial contributions and can be provided on the central level (EUPATI International) as well as at the national level (EUPATI National Platforms).
Project Funding/Grants
EUPATI participates regularly in calls for projects by e.g. IMI/IHI, the European Commission, EIT Health and other funding bodies, and has several ongoing projects. EUPATI’s role in these projects focuses on patient education and training.
